Podcast Episode
Episode 8: FDA Changes to the CAR-T Monitoring Program
About this episode
Dr. Saurabh Dahiya from Stanford University explains the recent changes in the FDA recommendations regarding the monitoring program previously mandated for centers delivering CAR-T therapies, and why this decision was celebrated by patients and their physicians.